Morphologie und Dysfunktion

• Literatur

• 1 Palkovitz M, Zaborsky L. Neural connections of the hypothalamus. In: Morgane PJ. (ed). Anatomy of the hypothalamus. New York: Decker; 1979
• 2 Bennett MR. The prefrontal-limbic network in depression: A core pathology of synapse regression. Prog Neurobiol 2011; 93 (04) 457-67.
• 3 Nieuwenhuys R, Voogd J, van Huijzen C. The human central nervous system. 4th ed. Berlin: Springer; 2008
• 4 Bao AM, Meynen G, Swaab DF. The stress system in depression and neurodegeneration: Focus on the human hypothalamus. Brain Research Reviews 2008; 57 (02) 531-53.
• 5 Swaab DF. Hypothalamic involvement in psychiatric disorders. In: Aminoff MJ, Boller F, Swaab DF. The human hypothalamus: Basic and clinical aspects. Handbook of clinical neurology. Amsterdam: Elsevier; 2003
• 6 Schönknecht P. Der Hypothalamus und seine Regulationsstörungen in der Pathophysiologie affektiver Erkrankungen. In: Becker R, Wunderlich HP. Gefühlsstrukturen und neuronale Grundlagen bipolarer Störungen. Stuttgart: Thieme; 2010
• 7 Schindler S. et al. Structural studies of the hypothalamus and its nuclei in mood disorders. Psychiatry Res Neuroimaging. 2011 doi: 10.1016/j.pscychresns.2011.06.005..
• 8 Card et al. The hypothalamus: An overview of regulatory systems in fundamental neurosciensce. Amsterdam: Elsevier; 2008
• 9 Kahl W, Frotscher M. Taschenatlas Anatomie. Band 3. Nervensystem und Sinnesorgane. Stuttgart: Thieme; 2009
• 10 Bogerts B. The neuropathology of schizophrenic diseases: historical aspects and present knowledge. Eur Arch Psychiatry Clin neurosci 1999; 249: 2-13.
• 11 Beyer JL, Krishnan KRR. Volumetric brain imaging findings in mood disorders. Bipolar Disord 2002; 04 (02) 89-104.
• 12 Konarski JZ, McIntyre RS, Kennedy SH, Rafi-Tari S, Soczynska JK, Ketter TA. Volumetric neuroimaging investigations in mood disorders: Bipolar disorder versus major depressive disorder. Bipolar Disord 2008; 10 (01) 1-37.
• 13 Kempton MJ, Geddes JR, Ettinger U, Williams SC, Grasby PM. Meta-analysis, database and meta-regression of 98 structural imaging studies in bipolar disorder. Archives of General Psychiatry 2008; 65 (09) 1017-32.
• 14 Drevets WC, Price JL, Furey ML. Brain structural and functional abnormalities in mood disorders: Implications for neurocircuitry models of depression. Brain Structure & Function 2008; 213 (1–2): 93-118.
• 15 Emsell L, McDonald C. The structural neuroimaging of bipolar disorder. International Review of Psychiatry 2009; 21 (04) 297-313.
• 16 Price JL, Drevets WC. Neurocircuitry of mood disorders. Neuropsychopharmacology 2010; 35 (01) 192-216.
• 17 Bielau H. et al. Volume deficits of subcortical nuclei in mood disorders. A postmortem study. Eur Arch Psychiatry Clin Neurosci 2005; 255: 401-12.
• 18 Holsboer F, Barden N. Antidepressants and hypothalamicpituitary-adrenocortical regulation. Endocr Rev 1996; 17: 187-205.
• 19 Raadsheer FC. et al. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer’s disease and depression. Am J Psychiatry 1995; 152: 1372-6.
• 20 Purba JS, Hoogendijk WJ, Hofman MA, Swaab DF. Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Arch Gen Psychiatry 1996; 53: 137-43.
• 21 Bernstein HG. et al. Nitric oxide synthase-containing neurons in the human hypothalamus: Reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics. Neuroscience 1998; 83: 867-75.
• 22 Bernstein HG. et al. Further immunohistochemical evidence for impaired NO signaling in the hypothalamus of depressed patients. Ann N Y Acad Sci 2002; 973: 91-3.
• 23 Schmidt FM. et al. Cerebrospinal fluid hypocretin-1 (orexin A) levels in mania compared to unipolar depression and healthy controls. Neuroscience Letters 2010; 483: 20-2.
• 24 Schmidt FM. et al. CSF-hypocretin-1 levels in patients with major depressive disorder compared to healthy controls. Psychiatry Research. 2011 in press.
• 25 Piguet O. et al. Eating and hypothalamus changes in behavioral-variant frontotemporal dementia. Ann Neurol 2011; 69 (02) 312-9.
• 26 Goldstein JM. et al. Hypothalamic abnormalities in schizophrenia: Sex effects and genetic vulnerability. Biological Psychiatry 2007; 61 (08) 935-45.
• 27 Koolschijn PC. et al. Hypothalamus volume in twin pairs discordant for schizophrenia. Eur Neuropsychopharmacol 2008; 18 (04) 312-5.
• 28 Solano-Castiella E. et al. Diffusion tensor imaging segments the human amygdala in vivo. Neuroimage 2010; 49: 2958-65.
• 29 Hegerl U. et al. EEG-vigilance differences between patients with borderline personality disorder, patients with obsessive-compulsive disorder and healthy controls. Eur Arch Psychiatry Clin Neurosci 2008; 258: 137-43.
• 30 Ulrich G. Psychiatrische Elektroenzephalographie. Jena: G. Fischer; 1994
• 31 van Sweden B. Disturbed vigilance in mania. Biological Psychiatry 1986; 21: 311-13.
• 32 Schönknecht P, Olbrich S, Sander C, Spindler P, Hegerl U. Treatment of acute mania with modafinil monotherapie. Biological Psychiatry 2010; 67: e55-57.
• 33 Schönknecht P. Der Hypothalamus und seine Regulationsstörungen in der Pathophysiologie affektiver Erkrankungen. In: Becker Wunderlich. (Hrsg.). Gefühlsstrukturen und neuronale Grundlagen bipolarer Störungen. Stuttgart: Thieme; 2010: 122-6.
• 34 Geyer S, Weiss M, Reimann K, Lohmann G, Turner R. Microstructural parcellation of the human cerebral cortex – from Brodmann’s post-mortem map to in vivo mapping with high-field magnetic resonance imaging. Front Hum Neurosci. 2011 doi: 10.3389/fnhum.2011.00019.